Overview
Hugo Armelin practices practicing medicine in Brasil, Brazil.
His clinical expertise encompasses Adrenocortical Carcinoma, Adrenal Cancer, and Human Papillomavirus Infection.
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hugo A. Armelin
Is Hugo A. Armelin a top-rated expert for Adrenocortical Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Hugo A. Armelin is classified as an Experienced expert for Adrenocortical Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hugo A. Armelin participate in research or clinical trials?
Yes. Hugo A. Armelin has published 15 articles and abstracts on conditions like Adrenocortical Carcinoma. You can view a list of Hugo A. Armelin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal CancerMr. Armelin isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaMr. Armelin isExperienced. Learn about Adrenocortical Carcinoma.
- Human Papillomavirus InfectionMr. Armelin isExperienced. Learn about Human Papillomavirus Infection.